NM_018129.4:c.674G>T

HGVS Expressions

  • NG_008744.1:g.10148G>T
  • NM_018129.4:c.674G>T
  • NP_060599.1:p.Arg225Leu
  • NC_000017.11:g.47946670G>T
Back to search Result
Clinvar Clinical Significance

Pathogenic

CTGA Clinical Significance

Pathogenic

Variant Type

Substitution

Clinvar

206451

Epidemiology in the Arab World

View Map
Subject IDCountry of OriginAllele CountAllele FrequencyCTGA Clinical Significance Condition(s)ReferenceRemarks
610090.1.1United Arab Emirates2PathogenicPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyFathalla et al. 2018
610090.1.2United Arab Emirates2PathogenicPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyFathalla et al. 2018 Sister of 610090.1.1
610090.2United Arab Emirates2PathogenicPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyFathalla et al. 2018 Patient had a brother with intractable e...
610090.3United Arab Emirates2PathogenicPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyFathalla et al. 2018 Belongs to the same tribe as 610090.1.1
610090.4United Arab Emirates2PathogenicPyridoxamine 5-Prime-Phosphate Oxidase DeficiencyFathalla et al. 2018 Belongs to the same tribe as 610090.1.1
© CAGS 2024. All rights reserved.